News | Computed Tomography (CT) | November 23, 2015

University of Wisconsin Carbone Cancer Center Adopts BodyTom for Brachytherapy Treatment

First center in the world to use BodyTom in the brachytherapy suite

CT scan

Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd. and a leading provider of advanced imaging solutions, announced today that the University of Wisconsin (UW) Carbone Cancer Center in Madison acquired and is incorporating NeuroLogica’s BodyTom technology into its radiation oncology brachytherapy planning process. UW Carbone Cancer Center is the first center in the world to use the BodyTom scanner for brachytherapy treatment.

The BodyTom CT further distinguishes UW Carbone Cancer Center, the state’s only National Cancer Institute-certified comprehensive cancer center that recently landed 15 physicians on Newsweek’s “Top Cancer Doctors 2015” list.The 32-slice portable CT scanner will be stationed in the brachytherapy suite, enabling patients to undergo radiation imaging, planning and treatment in a single location.

"Having in-room, high-quality CT imaging removes the need for patient transfer while under anesthesia during the procedure to a separate CT suite, and provides opportunities for pre- and post-implant quality assessment," said Greg Cooley, M.D., "and we can use the BodyTom CT in both of our suites without duplication of equipment for each room."

Radiation oncologists at UW Carbone Cancer Center use high-dose-rate (HDR) brachytherapy to treat forms of prostate, breast, gynecological and lung cancers. Radioactive sources are temporarily inserted inside tumors or areas of interest; this process enables precise delivery of high doses in a short time. The BodyTom produces high-quality, 3-D images to aid this process and can also be used to double-check the placement of radioactive implants, and make adjustments as necessary, without moving the patient.

“Hospital departments across the country recognize the value BodyTom can bring to patient care and efficient work practices,” said Philip Sullivan, Samsung NeuroLogica president and CEO. “Bringing BodyTom into the brachytherapy suite, especially one as well respected as UW’s Carbone Cancer Center, is a testament to BodyTom’s versatility.”

For more information: www.SamsungNeuroLogica.com.

Related Content

Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America
Videos | Radiation Therapy | August 13, 2018
A discussion with Mahadevappa Mahesh, MS, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor of radiology and cardiology and
Videos | Proton Therapy | August 10, 2018
A discussion with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico.
Videos | Radiomics | August 09, 2018
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada.
Videos | AAPM | August 03, 2018
Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke Un...
Videos | Radiation Therapy | August 01, 2018
This is an example of how Cherenkov radiation glow can be collected with image intensifier cameras during radiotherap
Videos | Artificial Intelligence | August 01, 2018
A discussion with Steve Jiang, Ph.D., director of the medical...
Videos | AAPM | August 01, 2018
American Association of Physicists in Medicine (AAPM) President Bruce Thomadsen, M.D., professor of medical physics a
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
Overlay Init